Intelligent Ultrasound shares skyrocket over 150% after first OEM agreement
Anita Riotta
Company News- 3 min read
10:49, 4th July 2019

Shares in Intelligent Ultrasound (MED) FOLLOW have skyrocketed over 150%, at one point reaching up to 180% of this morning’s opening share price, following a new deal with “one of the world's leading ultrasound equipment manufacturers.”

The agreement for Intelligent Ultrasound’s AI software marks the company’s first long-term licence and co-development deal.

At the center of the deal is the integration if Intelligent Ultrasound’s real-time image analysis software onto a range of specialized ultrasound systems. The AIM-listed company develops software to boost scanning quality in medical ultrasound specialties, such anaesthesiology, radiology and primary care medicine.

Work on co-development with the OEM partner has already begun with initial royalty per unit revenues expected in 2021 following regulatory approval.

CEO Stuart Gall commented, “This is a milestone agreement for the Group and we are delighted to have signed our first long-term agreement with one of the world's leading ultrasound companies. 

We believe that ScanNav is one of the world's first AI software products to provide real-time image analysis and guidance to sonographers during an ultrasound scan. We expect this to be the first of many agreements for our range of AI based image analysis software."

For more news and updates on Intelligent Ultrasound: FOLLOW

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Login or register to post comments

Recent Articles